Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes

Journal of Neurology

Volumn 253, Issue SUPPL. 5, 2006, Pages

  Voltz, Raymond ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Diagnosis; Immunoglobuline; Paraneoplastic syndrome; Tumor therapy

Indexed keywords

IMMUNOGLOBULIN; PYRIDOSTIGMINE;

CELL DIFFERENTIATION; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DERMATOMYOSITIS; DRUG EFFECT; EATON LAMBERT SYNDROME; GUILLAIN BARRE SYNDROME; HEMOLYTIC ANEMIA; HUMAN; MYASTHENIA GRAVIS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; STIFF MAN SYNDROME; TREATMENT OUTCOME;

HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PARANEOPLASTIC POLYNEUROPATHY;

EID: 33748978367     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-5005-z     Document Type: Conference Paper

References (43)

1. Albert ML, Darnell JC, Bender A et al. (1998) Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 4:1321-1324
2. Bain PG, Motomura M, Newsom-Davis J, Misbah SA, Chapel HM, Lee ML, Vincent A, Lang B (1996) Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology 47(3):678-683
3. Benyahia B, Liblau R, Merle-Beral H et al. (1999) Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol 45:162-167
4. Blaes F, Strittmatter M, Merkelbach S, Jost V, Klotz M, Schimrigk K, Hamann GF (1999) Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders. J Neurol 246(4):299-303
5. Bosi E, Bottazzo GF, Bonifacio E (2005) Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association. Clin Immunol 117(1):31-35
6. Buchwald B, Ahangari R, Weishaupt A, Toyka KV (2005) Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins. Muscle Nerve 31(4):487-494
7. Buckley C, Newsom-Davis J, Willcox N, Vincent A (2001) Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence? Neurology 57(9):1579-1582
8. Cosi V, Lombardi M Piccolo G, Erbetta A (1991) treatment of myasthenia gravis with high dose intravenous immunoglobulin. Acta Neurol Scand 84:81-84
9. Dalakas MC, Fujii M, Li M et al. (2001) High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 345:1870-1876
10. Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291(19):2367-2375
11. Dalakas MC (2005) The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies. J Neurol 252 (Suppl 1):I19-I25
12. Darnell RB, Posner JB (2003) Paraneoplastic syndromes involving the nervous system. N Engl J Med 349:1543-1554
13. Gajdos P, Chastang C, Clair B et al. (1994) For the myasthenia gravis clinical study group. First interim analysis of a randomized clinical trial comparing plasma exchange and intravenous immunoglobulin in myasthenia gravis. Neuromusc Disord 4:S51
14. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler Ch, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75(8):1135-1140
15. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357(9250):96-100
16. Illa I (2005) IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status. J Neurol 252(Suppl 1):I14-I18
17. Lindenbaum Y, Kissel JT, Mendell JR (2001) Treatment approaches for Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Neurol Clin 19(1):187-204
18. Maddison P, Newsom-Davis J (2005) Treatment for Lambert-Eaton myasthenic syndrome. Cochrane Database Syst Rev 2:CD003279
19. Muchnik S, Losavio AS, Vidal A et al. (1997) Long term follow up of Lambert Eaton syndrome treated with intravenous immunoglobulin. Muscle Nerve 20:674-678
20. Murinson BB, Butler M, Marfurt K, Gleason S, De Camilli P, Solimena M (2004) Markedly elevated GAD antibodies in SPS: effects of age and illness duration. Neurology 63(11):2146-2148
21. Murinson BB, Vincent A (2001) Stiff-person syndrome: autoimmunity and the central nervous system. CNS Spectr 6(5):427-433
22. Newsom-Davis J (2004) Lambert-Eaton myasthenic syndrome. Rev Neurol (Paris) 60(2):177-180
23. Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127(Pt 3):701-712
24. Pellkofer H, Schubart AS, Hoftberger R, Schutze N, Pagany M, Schuller M, Lassmann H, Hohlfeld R, Voltz R, Linington C (2004) Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. Brain 127(Pt 8):1822-1830
25. Piquer S, Belloni C, Lampasona V, Bazzigaluppi E, Vianello M, Giometto B, Bosi E, Bottazzo GF, Bonifacio E (2005) Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association. Clin Immunol 117:31-35
26. Posner JB (1995) Paraneoplastic syndromes. In: Posner JB (ed) Neurologic complications of cancer. Contemporary Neurological Series, FA Davis, pp 353-385
27. PSGBS-Study group (1997) Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Lancet 349(9047):225-230
28. Qureshi AI, Choudhry MA, Akbar MS, Mohammad Y, Chua HC, Yahia AM, Ulatowski JA, Krendel DA, Leshner RT (1999) Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis. Neurology 52(3):629-632
29. Rakocevic G, Raju R, Dalakas MC (2004) Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch Neurol 61(6):902-904
30. Rich MR, Teener JW, Bird SJ (1997) Treatment of Lambert Eaton syndrome with intravenous immunoglobulin. Muscle Nerve 20:614-615
31. Sommer C, Weishaupt A, Brinkhoff J, Biko L, Wessig C, Gold R, Toyka KV (2005) Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 365(9468):1406-1411
32. Uchuya M, Graus F, Vega F, Rene R, Delattre JY (1996) Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 60(4):388-392
33. van der Meche FG, Schmitz PI (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med 326(17):1123-1129
34. Van der Meche FGA, van Doorn PA (1997) The current place of high dose immunoglobulins in the treatment of neuromuscular disorders. Muscle Nerve 20:136-147
35. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy- responsive form of limbic encephalitis. Brain 127(Pt 3):701-712
36. Voltz R, Albrich W, Kirchner T, Nagel D, Wick M, Sommer N, Illa I, Kaminski H, Schumm F, Hohlfeld R (2003) Anti-titin antibodies are not associated with a specific thymoma histology. J Neurol Neurosurg Psychiat 74:282
37. Voltz R, Dalmau J, Posner JB, Rosenfeld MR (1998) T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 51:1146-1150
38. Voltz R, Gultekin SH, Rosenfeld MR et al. (1999) A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 340:1788-1795
39. Voltz R (2002) Paraneoplastic neurological syndromes: An update on diagnosis, pathogenesis and therapy. The Lancet Neurology 1:294-305
40. Voltz RD, Albrich WC, Nagele A et al. (1997) Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. Neurology 49:1454-1457
41. Wessig C, Klein R, Schneider MF, Toyka KV, Naumann M, Sommer C (2003) Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome. Neurology 61(2):195-198
42. Widdess-Walsh P, Tavee JO, Schuele S, Stevens GH (2003) Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature. J Neurooncol 63(2):187-190
43. Wolfe GI, Barohn RJ, Foster BM, Jackson CE, Kissel JT, Day JW, Thornton CA, Nations SP, Bryan WW, Amato AA, Freimer ML, Parry GJ (2002) Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis. Muscle Nerve 26(4):549-552